» Articles » PMID: 34253754

Stage-dependent Choriocapillaris Impairment in Best Vitelliform Macular Dystrophy Characterized by Optical Coherence Tomography Angiography

Overview
Journal Sci Rep
Specialty Science
Date 2021 Jul 13
PMID 34253754
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Characterization of vascular impairment in Best vitelliform macular dystrophy (BVMD) is essential for the development of treatment modalities and therapy trials. As such, we seek to characterize the choriocapillaris (CC) at each stage of the disease process in 22 patients (44 eyes) with a diagnosis of BVMD confirmed by genetic sequencing. We utilize optical coherence tomography angiography (OCTA) images to characterize the CC and correlate our findings to the status of the retinal pigment epithelium (RPE) as observed on short-wavelength fundus autofluorescence (SW-AF) images. We observed that in the vitelliruptive stage, the CC appeared as bright and granular in the area where the vitelliform lesion was present. In the atrophic stage, varying degrees of CC atrophy were observed within the lesion area, with the regions of CC atrophy appearing as hypoautofluorescent on SW-AF images. Our results suggest that the CC impairment observed in the vitelliruptive stage of BVMD progressively culminates in the CC atrophy observed at the atrophic stage. As such, OCTA imaging can be used to characterize CC impairment in BVMD patients as part of diagnosis and tracking of disease progression. Our findings suggest that the best window of opportunity for therapeutic approaches is before the atrophic stage, as it is during this stage that CC atrophy is observed.

Citing Articles

Retinal Imaging Findings in Inherited Retinal Diseases.

Corradetti G, Verma A, Tojjar J, Almidani L, Oncel D, Emamverdi M J Clin Med. 2024; 13(7).

PMID: 38610844 PMC: 11012835. DOI: 10.3390/jcm13072079.


Clinical Applications of Optical Coherence Tomography Angiography in Inherited Retinal Diseases: An Up-to-Date Review of the Literature.

Iovino C, Iodice C, Pisani D, Damiano L, Di Iorio V, Testa F J Clin Med. 2023; 12(9).

PMID: 37176614 PMC: 10179546. DOI: 10.3390/jcm12093170.


Multimodal imaging in Best Vitelliform Macular Dystrophy: Literature review and novel insights.

Bianco L, Arrigo A, Antropoli A, Berni A, Saladino A, Vilela M Eur J Ophthalmol. 2023; 34(1):39-51.

PMID: 36972471 PMC: 10757402. DOI: 10.1177/11206721231166434.

References
1.
Jauregui R, Cho G, Takahashi V, Takiuti J, Bassuk A, Mahajan V . Caring for Hereditary Childhood Retinal Blindness. Asia Pac J Ophthalmol (Phila). 2018; 7(3):183-191. DOI: 10.22608/APO.201851. View

2.
Zhang Y, Stanton J, Wu J, Yu K, Hartzell H, Peachey N . Suppression of Ca2+ signaling in a mouse model of Best disease. Hum Mol Genet. 2010; 19(6):1108-18. PMC: 2830833. DOI: 10.1093/hmg/ddp583. View

3.
Sacconi R, Corbelli E, Carnevali A, Querques L, Bandello F, Querques G . OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN GEOGRAPHIC ATROPHY. Retina. 2017; 38(12):2350-2355. DOI: 10.1097/IAE.0000000000001873. View

4.
Guduru A, Gupta A, Tyagi M, Jalali S, Chhablani J . Optical coherence tomography angiography characterisation of Best disease and associated choroidal neovascularisation. Br J Ophthalmol. 2017; 102(4):444-447. DOI: 10.1136/bjophthalmol-2017-310586. View

5.
Battaglia Parodi M, Romano F, Cicinelli M, Rabiolo A, Arrigo A, Pierro L . Retinal Vascular Impairment in Best Vitelliform Macular Dystrophy Assessed by Means of Optical Coherence Tomography Angiography. Am J Ophthalmol. 2017; 187:61-70. DOI: 10.1016/j.ajo.2017.12.013. View